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Sepsis is a major clinical challenge, especially to clinicians working 
in emergency and critical care units. Research over the last 
decade into a better understanding of the pathophysiology and 
management of sepsis has resulted in a remarkable increase of new 
knowledge on the subject. Some findings translate into improved 
outcomes, while others lack reproducibility in large clinical trials.
Sepsis is a clinical syndrome characterised by systemic inflammation 
(SIRS) due to infection. Although inflammation is an essential and 
beneficial host response, sepsis involves a dysregulation of the 
normal inflammatory process. The result is an uncontrolled release 
of pro-inflammatory mediators that, coupled with the release of 
bacterial toxins, induce widespread tissue injury. As this process 
invariably occurs within the vasculature, most of the damage is to 
the endothelium. The endothelium is not a passive surface, and 
is widely involved in maintenance of circulating volume and in 
coagulation and fibrinolysis.1-4
A spectrum of clinical disease follows: when the infection 
produces multiple systemic symptoms, such as fever and increased 
respiratory or heart rate, the syndrome is referred to as sepsis; if 
the systemic response to infection progresses and causes evidence 
of organ dysfunction distant from the site of infection, patients 
are classified as having severe sepsis; septic shock is defined as 
severe organ dysfunction with hypotension or hypoperfusion not 
responsive to initial fluid resuscitation (Table I).1-7
As sepsis progresses to septic shock, the risk of dying increases 
substantially. Where sepsis is usually reversible with early 
appropriate therapy, patients with septic shock have a mortality of 
40 - 60% despite aggressive therapy.3,4,7,8
Risk factors for developing sepsis3,4,8-10
The risk for developing sepsis depends mainly on the presence of 
co-morbid conditions associated with immune defects and/or the 
use of immunosuppressive therapies. The site of primary infection 
and the specific infecting microbe plays an additional role while 
genetic factors may also be important.
Advanced age, lack of splenic function, alcoholism with significant 
liver disease, chronic renal disease, intravenous drug use, 
malnutrition, HIV infection, diabetes mellitus and malignancy all 
predispose to specific infections, frequently with increased severity. 
Cancer chemotherapy, immunosuppressive therapies after organ 
transplantations and chronic steroid therapy also increase the risk 
for sepsis.
Certain sites of primary infection may provide a nidus for bacterial 
invasion: recent upper or lower respiratory tract infections, prior 
major trauma, disruption of cutaneous barriers due to lacerations, 
burns, surgery or decubiti ulcers and the presence of foreign material 
such as nasal packing, barrier contraceptives, tampons, arteriovenous 
fistulas, indwelling catheters, prosthetic joints and mechanical 
ventilation are all associated with an increased risk for sepsis.
Specific organisms that may predispose to more severe infection 
are often associated with the above risk factors and include 
Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, 
Staphylococcus aureus and Streptococcus pneumoniae. Circulating 
bacteria and their products may also directly stimulate inflammatory 
responses within the vasculature, e.g. meningococcal endotoxin, 
or inflammatory mediators from the local site of infection, e.g. 
penumonia caused by P. aeruginosa. 
Clinical manifestations of the septic 
response3,4
Clinical manifestations are nonspecific and usually superimposed 
on the symptoms and signs of the patient’s underlying illness 
and primary infection. There are striking individual variations in 
presentation and the rate at which symptoms develop may differ 
from patient to patient.
Patients usually present with fever or hypothermia. A 
normal temperature on presentation is uncommon but may 
occur in neonates, the elderly, alcoholics and the severely 
immunosuppressed.
Early symptoms and signs may include hyperventilation and 
sometimes confusion or disorientation. Signs of encephalopathy 
are more common in the elderly and in individuals with pre-
existing neurological disorders. Focal neurological deficits are not 
usually a feature of sepsis, but existing deficits may become more 
prominent in the septic patient.
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On occasion, skin lesions that suggest a 
specific pathogenic aetiology may be present 
at the sites of haematogenous seeding of 
organisms and/or toxins to the skin (Table 
II).
Nausea, vomiting, diarrhoea and ileus are 
usually nonspecific manifestations of the 
septic response, but may suggest acute 
gastroenteritis as primary infection. 
Laboratory findings3,4
Early abnormalities include leucocytosis or 
leucopenia, thrombocytopenia (up to 30% 
of patients), and proteinuria.  Neutrophils 
may contain toxic granulations or 
cytoplasmic vacuoles.
With progression of the septic response 
thrombocytopenia becomes more 
severe (<50 000) and if accompanied 
by prolongation of the thrombin time, 
decreased fibrinogen and increased 
D-dimers are highly suggestive of DIC. 
Active haemolysis with fragments on the 
blood smear strengthens the diagnosis of 
DIC. 
Abnormal liver enzymes are a common 
early manifestation of sepsis and may 
include cholestatic jaundice with 
elevated serum conjugated bilirubin and 
alkaline phosphatase. Prolonged severe 
hypotension may cause marked elevation 
of transaminases due to ischaemic 
hepatocyte necrosis. 
During the septic response tissues cannot 
extract oxygen from the blood as normal, 
resulting in anaerobic metabolism. Blood 
lactate levels rise early and eventually lead 
to metabolic acidosis. Hyperglycaemia is 
often present, mostly in diabetics, and may 
trigger diabetic ketoacidosis. 
Hyperventilation during early sepsis may 
lead to respiratory alkalosis, but this is 
soon replaced by metabolic acidosis (with 
increased anione gap) due to respiratory 
fatigue and hyperlactataemia. 
The acute phase response results in 
increased production of C-reactive protein, 
ferritin, fibrinogen and complement 
components. 
Chest radiograph findings vary from 
normal to pneumonic consolidation to 
fluid overload and the diffuse infiltrates 
of acute respiratory distress syndrome 
(ARDS), depending on the underlying 
disease process. ECG usually shows a 
Table I. Explanation of terms used 
Infection Presence of a micro-organism in a normally sterile site – differentiate from  colonisation
Bacteraemia Bacteria cultured from blood – poor correlation with severe sepsis, may be transient without any clinical 
consequences
Systemic inflam-
matory response 
syndrome (SIRS)
Systemic inflammation due to infectious and non-infectious triggers.  
Two or more of the following:
   •  Temperature >38oC or <363 ptC
   •  Heart rate > 90 beats/min
   •  Respiratory rate >20 breaths/min or PaCO2 <4 kPa
   •  WCC > 12 000cell/mm3 or <4 000cells/mm3 or >10% immature (band) forms
Sepsis If SIRS is associated with infection (proven or suspected)
Hypotension Systolic blood pressure of < 90 mmHg; MAP <70 mmHg or a reduction of >40 mmHg from baseline  
(exclude other causes for hypotension)
Tissue hypoperfu-
sion
Manifests as one or more of the following:
   •  Septic shock
   •  Serum lactate >2.0 mmol/l
   •  Oliguria (<0.5 ml/kg per hour)
Severe sepsis Sepsis associated with dysfunction of organ(s) distant from the site of infection – hypotension or hypoperfu-
sion, if present, must be reversible with adequate fluid resuscitation
Septic shock Sepsis-induced hypotension not responding to adequate fluid resuscitation and requiring vasopressor 
therapy
Refractory sepsis Septic shock for >1 hour, not responding to vasopressor therapy
Table II. Skin lesions in severely ill patients associated with specific aetiological agents
Skin lesion Clinical associations Pathogen
Petichae and/or purpura Meningitis Neisseria meningitides 
Tick bite Tick bite fever, Crimean-Congo haemorrhagic fever 
Dog bite Capnocytophaga canimorsus
Ecthyma gangrenosum (bullous 
with central haemorrhage/ne-
crosis)
Neutropenia Pseudomonas aeruginosa
Generalised erythroderma Toxic shock syndrome Staphylococcus aureus or Streptococcus pyogenes
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sinus tachycardia and sometimes some 
nonspecific ST-T wave abnormalities. 
Complications3,4,6,7
Early in the course of sepsis, increasing 
alveolar capillary permeability causes 
increased pulmonary water content, 
which interferes with oxygen exchange 
and results in ventilation perfusion 
mismatching and a fall in PO2. Progressive 
diffuse pulmonary infiltrates and arterial 
hypoxaemia (PaO2/FIO2 <200) indicate the 
development of ARDS. Failure (fatigue) of 
respiratory muscles further exacerbates 
hypoxaemia and hypercapnia. ARDS 
must be differentiated from fluid overload, 
cardiac failure, viral pneumonitis and 
pneumocystis pneumonia.
Sepsis-induced hypotension develops from 
general microcirculatory maldistribution 
of blood flow and blood volume, and from 
hypovolaemia due to capillary leakage of 
intravascular fluid. Dehydration secondary 
to insensible fluid losses, diarrhoea, 
vomiting and polyuria also contribute. 
During early septic shock systemic 
vascular resistance is usually elevated 
and cardiac output decreased. After 
fluid repletion, cardiac output typically 
increases, but systemic vascular resistance 
falls. Increased or normal cardiac output 
and decreased systemic vascular resistance 
is the hallmark of septic shock. Other 
conditions that may cause this combination 
include anaphylaxis, liver cirrhosis, and an 
overdose of narcotics.
Depressed myocardial function (low 
ejection fraction) develops within 24 
hours in most patients with severe sepsis. 
Cardiac output is, however, maintained 
because ventricular dilatation permits 
a normal stroke volume. Although 
myocardial dysfunction may contribute 
to hypotension, refractory hypotension is 
usually due to the low systemic vascular 
resistance.
Decreased urinary output is often present, 
but some patients may be inappropriately 
polyuric. Renal failure is usually due to 
acute tubular necrosis (ATN), induced by 
hypotension or capillary injury. ATN may 
be aggravated by giving hypovolaemic 
patients aminoglycoside antibiotics. 
Diagnosis3,4,6,11
There is no specific diagnostic test for 
the septic response. The classic septic 
parameters are sensitive clinical findings 
for infection and include fever or 
hypothermia, tachypnoea, tachycardia and 
leukocytosis or leukopenia. An acutely 
altered mental state, thrombocytopenia, 
raised serum lactate and hypotension 
further increase the clinical suspicion for 
sepsis. The septic response can however be 
varied and patients with sepsis can present 
without many of the typical clinical 
findings. Conversely, patients may present 
with all the clinical features of systemic 
inflammation but without an infectious 
cause (Table III).
A definitive aetiological diagnosis requires 
isolation of a micro-organism. At least 2 
blood culture samples should be obtained 
from different venepuncture sites. 
Microbial invasion of the bloodstream 
is not essential for the development of 
sepsis, since local infection can also cause 
a systemic inflammatory response with 
organ dysfunction.  It is therefore crucial 
to culture material from the primary site 
of infection or from infected cutaneous 
lesions wherever possible.
Cultures often remain negative despite a 
definitive presence of an infection. Negative 
cultures may be due to recent antimicrobial 
use, presence of slow growing or fastidious 
organisms or the absence of microbial 
invasion of the bloodstream. 
Treatment1,3,5,6,11
Successful management of suspected 
sepsis requires urgent measures to treat 
the local site of infection, to provide 
haemodynamic and respiratory support 
and to eliminate the offending micro-
organism. The patient’s underlying disease 
must also be managed aggressively. Rapid 
assessment and diagnosis is essential to 
facilitate the initiation of these measures 
within the first 6 hours after presentation.
Antimicrobial agents should be started 
immediately after samples from blood, 
urine and other clinically relevant sites 
have been taken for culture. Studies 
have shown that starting appropriate 
antimicrobial chemotherapy within 1 
hour after presentation with septic shock 
is associated with improved survival 
rates. Knowledge of the likely pathogen at 
specific sites of local infection and of the 
most recent data on susceptibility patterns 
of bacterial isolates from the hospital and 
the community is essential in making an 
appropriate antibiotic choice. As a rule 
initial empiric antibiotic cover must be 
effective against both Gram-negative 
and Gram-positive bacteria. Maximum 
recommended antibiotic doses must be 
given intravenously. Duration of therapy is 
usually 7 - 10 days, but is influenced by the 
response to treatment, the site of infection, 
the adequacy of surgical drainage, 
underlying co-morbid disease and the 
susceptibility of the bacterial isolate. 
Removal or drainage of a local source of 
infection is essential. The risks and benefits 
of the specific method of source control 
must be considered carefully. Invasive 
devices must be removed where possible 
and sent for culture. Where the source 
of infection is not clear, occult infection 
should be sought. 
Adequate organ perfusion is essential for 
proper oxygen and substrate delivery to the 
tissues. Effective intravascular depletion 
is common in patients with sepsis and 
initial management of hypotension should 
include administration of 1 - 2 litres of 
Ringer’s lactate over 1 - 2 hours guarding 
against fluid overload by keeping the CVP 
between 8 and 12 cmH2O. Normal saline is 
not recommended for initial resuscitation 
due to the increased risk of developing 
hyperchloraemic metabolic acidosis. Aim 
for a urine output rate of ≥0.5 ml/kg per 
hour and try to keep the MAP ≥65 mmHg 
(systolic blood pressure above 90 mmHg). 
Adequate fluid volume replacement 
does not necessarily equate to proper 
microcirculatory tissue perfusion.  Serial 
lactate measurements are very helpful to 
assess organ perfusion and levels of <2 
reflect adequate perfusion. Circulatory 
adequacy should also be assessed by 
clinical parameters (mentation, urine 
output, skin perfusion). If unable to obtain 
these goals with fluid therapy inotropic 
and vasopressor therapy is indicated. 
A low haemoglobin concentration (<7 
g/dl) will impair oxygenation. Blood 
transfusion is indicated to keep the 
haemoglobin between 7 and 9 g/dl. 
Mechanical ventilation is indicated for 
progressive hypoxaemia, hypercapnoea, 
neurological deterioration or respiratory 
muscle failure. Sustained tachypnia 
(>30 breaths/min) is frequently a sign 
of impending respiratory collapse and 
early ventilation will ensure adequate 
oxygenation, divert blood from the 
muscles of respiration, reduce the cardiac 
afterload and prevent aspiration. 
Table III. Non-infectious aeti-
ologies of SIRS
Pancreatitis
Burns
Trauma
Myocardial infarction
Pulmonary embolism
Dissecting aortic aneurism
Cardiac tamponade 
Adrenal insufficiency
Anaphylaxis
Drug overdose 
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DIC, if complicated by severe bleeding, 
should be treated with fresh frozen plasma 
and platelets. Bicarbonate may sometimes 
be used in severe refractory metabolic 
acidosis. However, successful treatment 
of the infection is essential to reverse 
both DIC and acidosis. Patients with 
acute renal failure may benefit from either 
haemofiltration or haemodialysis. 
Important preventive measures to assist 
recovery include prevention of skin 
breakdown (skin care), deep venous 
thrombosis (heparin), nosocomial 
infections (infection control) and stress 
ulcers (H2 blockers or PPIs).
Other measures11-15
Despite aggressive management many 
patients with severe sepsis and septic shock 
still die. Treatment modalities that may 
prevent these deaths have been investigated 
in depth and include early goal-directed 
therapy (EGDT), tight glucose control, 
physiological steroid replacement and 
recombinant activated protein C. 
EGDT is an algorithm for the acute 
management of sepsis published by Rivers 
in 2001. It is used for the first 6 hours 
after a patient presents to the emergency 
unit. Following the algorithm resulted 
in a 16% reduction in 28-day mortality 
compared with controls. The main clinical 
goals of EGDT are early recognition of 
disease, and improving of indices of organ 
perfusion, including blood pressure (MAP 
≥65 mmHg), serum lactate concentration 
(<2 mmol/l) and central venous oxygen 
saturation (≥70%). Early appropriate 
antibiotics and control of the source of 
infection are other important factors. 
EGDT is strongly recommended, but the 
findings still need to be validated in large 
prospective trials.
Initial data showing improved outcomes 
with tight glycaemic control (4.4 - 6.1 
mmol/l) could not be reproduced in 
follow-up studies. Insulin infusions 
require intensive protocol-driven control 
measures and are often complicated 
by hypoglycaemia. Although adequate 
glycaemic control (aim for ≤8.3 mmol/l) 
is still part of standard care, most ICU 
specialists have abandoned the practice of 
tight glycaemic control. 
Adrenal insufficiency should be 
considered in septic patients with 
refractory hypotension, fulminant 
Neisseria meningitidis bacteraemia, 
prior glucocorticoid use, disseminated 
tuberculosis and AIDS. The CORTICUS 
trial on low-dose hydrocortisone was also 
not able to reproduce results of earlier 
trials with improved outcomes. It is, 
however, acceptable to give hydrocortisone 
50 mg IVI 6-hourly as a therapeutic trial 
to a subset of patients with septic shock 
not responding to adequate fluid and 
vasopressor therapy. If improvement 
follows in the next 24 - 48 hours, continue, 
tapering the dose over 5 - 7 days. 
The use of activated protein C has been 
the subject of controversy ever since 
the publication of the PROWESS trial 
results in 2001. The study was terminated 
prematurely on the grounds of efficacy. 
Other studies have however failed to 
show benefit and the current international 
guideline on the management of severe 
sepsis does not recommend its routine 
use. 
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•    Some findings translate into improved 
outcomes, while others lack reproducibility 
in large clinical trials.
•    Sepsis involves a dysregulation of the normal 
inflammatory process.
•    When the infection produces multiple 
systemic symptoms, such as fever and 
increased respiratory or heart rate, the 
syndrome is referred to as sepsis.
•    If the systemic response to infection progresses 
and causes evidence of organ dysfunction 
distant from the site of infection, patients are 
classified as having severe sepsis.
•    Septic shock is defined as severe organ 
dysfunction with hypotension or 
hypoperfusion not responsive to initial fluid 
resuscitation.
•    Where sepsis is usually reversible with early 
appropriate therapy, patients with septic 
shock have a mortality of 40 - 60% despite 
aggressive therapy.
•    The risk for developing sepsis depends mainly 
on the presence of co-morbid conditions 
associated with immune defects and/or the 
use of immunosuppressive therapies.
•    Early in the course of sepsis, increasing 
alveolar capillary permeability causes 
increased pulmonary water content, which 
interferes with oxygen exchange and results 
in ventilation perfusion mismatching and a 
fall in PO2.
•    There is no specific diagnostic test for the 
septic response.
•    Successful management of suspected sepsis 
requires urgent measures to treat the local 
site of infection, to provide haemodynamic 
and respiratory support and to eliminate the 
offending micro-organism.
In a nutshell
There are 
striking individual 
variations in 
presentation and 
the rate at which 
symptoms develop 
may differ from 
patient to patient.
